azacitidine

The medicine is used in adults who are not candidates for stem cell transplantation, for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: Seacross Pharma (Europe) Limited

The medicine is used in adults with high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are bone marrow diseases that make it difficult to produce blood cells correctly.

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.

The medicine is used in adults who are not eligible for stem cell transplantation, for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection solution

ATC: L01BC07

Manufacturer: AqVida GmbH

The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).

Form: tablets, film-coated

ATC: L01BC07

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).

Form: tablets, film-coated

ATC: L01BC07

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used in adults for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are bone marrow diseases that make it difficult to produce blood cells correctly.

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used in adults (who are not eligible for stem cell transplantation) for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: Wessling GmbH

The medicine is used in adults (who are not eligible for stem cell transplantation) to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: AqVida GmbH

The medicine is used in adults for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are diseases that affect the bone marrow.

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Limited, Salutas Pharma GmbH

The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).

Form: tablets, film-coated

ATC: L01BC07

Manufacturer: Adalvo Limited

This medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission). It works by preventing the growth of cancer cells.

Form: tablets, film-coated

ATC: L01BC07

Manufacturer: Adalvo Limited

The medicine is used in adults to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: Pharmadox Healthcare Ltd., STADA Arzneimittel AG

The medicine is used in adult patients for the treatment of high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. These are diseases that affect the bone marrow.

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: APIS Labor GmbH

The medicine is used in adults for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are diseases that affect the bone marrow.

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: Seacross Pharma (Europe) Limited

The medicine is used in adults to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: AqVida GmbH, STADA Arzneimittel AG

The medicine is used in adults (who are not eligible for stem cell transplantation) for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Form: powder for preparation of injection suspension

ATC: L01BC07

Manufacturer: AqVida GmbH

The medicine is used in adult patients for the treatment of high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. These are diseases that affect the bone marrow.

Form: powder for preparation of injection suspension or injection solution

ATC: L01BC07

Manufacturer: AqVida GmbH